同益中2021年第三季度报告

同益股份：2021年第三季度报告

广东邦宝益智玩具股份有限公司2021年第三季度报告

创益通：2021年第三季度报告

裕同科技：2021年第三季度报告

艾媒报告|2019-2021年中国中药材行业发展现状及产业链分析报告

本报告研究涉及企业/品牌/案例：白云山,同仁堂,云南白药,昆明制药,华润三九,天士力,央视财经,牛黄,薏仁,茯苓,黄芪,川芎,片仔癀,中国中药,紫鑫药业,九洲药业,陇神戎发,众生药业,通化金马,江中药业,寿仙谷,新天药业,盘龙药业,佛慈制药,昆药集团,香雪制药,六味地黄丸,人参养荣丸,四神丸,白蚀丸,血脂康胶囊,茵栀黄口服液,一捻金胶囊,乙肝益气解郁颗粒,二十七味定坤丸,十六味冬青丸,参芪消渴胶囊,十香返生丸,华润三九,红日药业,源和药业,太龙药业,中智药业，培力控股,盛实百草,芍花堂,亳药千草,汇群中药

国内经济增长以及居民消费水平的提高都刺激着中药医疗消费需求的增长。iiMedia Research（艾媒咨询）调查显示，有49%的受访用户倾向中医药治疗，与西药基本持平。2018年中国中药材市场规模达1246亿元，同比增长22.40%，在巨大的需求驱动下，中药材种植面积扩大，药材产量将会持续增长。

中药材主要包括上游种植、养殖市场，中游流通市场和下游销售市场三大环节。目前，中药饮片和中成药生产是中药产业的核心，主要包括中药加工，包括中药配方颗粒、中药饮片加工、中成药制造等。中药饮片领域方面，行业销售收入增速分别在2016和2018年触底回升，华润三九、中国中药、红日药业等上市公司表现良好；中药配方颗粒方面，2006-2016年，中国市场销售额占饮片市场销售额比重由1.2%增加至6.0%，中药配方颗粒或将成为中药饮片加工行业应用广泛的产品；中成药方面，随着国家医改政策的推行，中成药消费需求趋于合理，中成药产量开始回落，但仍处于一个比较高的产量水平，云南白药、白云山、同仁堂、紫鑫药业等上市企业表现良好。

Chinese medicinal materials mainly include upstream planting, breeding market, midstream circulation market and downstream sales market three links. At present, the production of Chinese medicine tablets and traditional Chinese medicine is the core of the Chinese medicine industry, including the processing of Traditional Chinese medicine, including Chinese medicine formula particles, Chinese medicine tablet processing, traditional Chinese medicine manufacturing. In the field of Chinese medicine tablets, the growth rate of sales revenue in the industry rebounded in 2016 and 2018, respectively, china Resources 39, Chinese medicine, Red Day Pharmaceuticals and other listed companies performed well; Chinese medicine formula particles may become a widely used product in the Chinese medicine tablet processing industry, Chinese medicine, with the implementation of the national medical reform policy, the consumption demand of traditional Chinese medicine tends to be reasonable, the production of Traditional Chinese medicine began to fall, but still at a relatively high level of production, Yunnan White Medicine, Baiyunshan, Tongrentang, Zixin Pharmaceutical and other listed enterprises performed well.

艾媒报告丨2018上半年中国金融科技专题研究报告（财富管理篇）

财富管理类金融科技产品目前呈现良好发展势头，而各类产品中，独立第三方平台推出的产品发展最为迅猛。iiMedia Research(艾媒咨询)数据显示，近三成用户未来倾向使用独立第三方企业推出的财富管理应用，为增长潜力最高的财富管理应用类型。具备服务专业化、多样化的第三方平台未来将对传统金融机构和互联网巨头财富管理产品形成冲击。

艾媒报告|2019中国电子签名安全专题研究报告

本报告研究涉及企业/品牌/案例：上上签,法大大,e宝签,中国云签,契约锁

在互联网行业高速发展下，企业对电子合同签署的安全需求日益升级，安全问题成行业焦点。国家也出台相关政策法规规范行业整体发展，电子商务的健康发展协同中国电子签名行业的安全升级。在电子合同签署过程中，电子合同服务包括实名认证、合同签署、数据存证和司法落地四大板块，法律效力和安全性是服务的关键所在，资质认证和核心技术赋能服务企业发展。当前，中国第三方电子签名服务平台整体已进入整合阶段，相关运营资质与监管文件逐步健全和完善。电子签名企业需依靠领先的技术创新优势突围，提升企业研发实力，未来才能够在行业内站稳脚跟。在市场竞争中，上上签、法大大为等头部企业将得到更多企业用户的青睐。

With the rapid development of the Internet industry, enterprises' security requirements for electronic contract signing are increasingly upgraded, and security issues have become the focus of the industry. The state also issued relevant policies and regulations to regulate the overall development of the industry, the healthy development of e-commerce and China's electronic signature industry security upgrade. In the process of electronic contract signing, electronic contract services include real-name authentication, contract signing, data storage and judicial execution. Legal effectiveness and security are the key to the services. Qualification authentication and core technology enable the development of enterprises. At present, China's third-party electronic signature service platform has entered the integration stage as a whole, and the relevant operation qualification and regulatory documents have been gradually improved and improved. Electronic signature enterprises need to rely on leading technological innovation advantages to break through, enhance the strength of enterprise research and development, in the future to be able to stand firm in the industry. In market competition, sign on, law is the head enterprise such as major will get the favour of more enterprise user.

嘉益股份：2021年第三季度报告

同庆楼2021年第三季度报告